Cited by — An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain.
No admitted local citation edges point to this work yet.
